Cargando…

Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study

Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods:...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mihui, Yang, Yong Sook, Ko, Young-Guk, Choi, Mona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102344/
https://www.ncbi.nlm.nih.gov/pubmed/35566674
http://dx.doi.org/10.3390/jcm11092547
_version_ 1784707306462642176
author Kim, Mihui
Yang, Yong Sook
Ko, Young-Guk
Choi, Mona
author_facet Kim, Mihui
Yang, Yong Sook
Ko, Young-Guk
Choi, Mona
author_sort Kim, Mihui
collection PubMed
description Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan–Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan–Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.
format Online
Article
Text
id pubmed-9102344
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91023442022-05-14 Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study Kim, Mihui Yang, Yong Sook Ko, Young-Guk Choi, Mona J Clin Med Article Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan–Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan–Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD. MDPI 2022-05-01 /pmc/articles/PMC9102344/ /pubmed/35566674 http://dx.doi.org/10.3390/jcm11092547 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kim, Mihui
Yang, Yong Sook
Ko, Young-Guk
Choi, Mona
Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
title Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
title_full Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
title_fullStr Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
title_full_unstemmed Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
title_short Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study
title_sort major adverse events in patients with peripheral artery disease after endovascular revascularization: a retrospective study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102344/
https://www.ncbi.nlm.nih.gov/pubmed/35566674
http://dx.doi.org/10.3390/jcm11092547
work_keys_str_mv AT kimmihui majoradverseeventsinpatientswithperipheralarterydiseaseafterendovascularrevascularizationaretrospectivestudy
AT yangyongsook majoradverseeventsinpatientswithperipheralarterydiseaseafterendovascularrevascularizationaretrospectivestudy
AT koyoungguk majoradverseeventsinpatientswithperipheralarterydiseaseafterendovascularrevascularizationaretrospectivestudy
AT choimona majoradverseeventsinpatientswithperipheralarterydiseaseafterendovascularrevascularizationaretrospectivestudy